Targeting cancer-associated fibroblast-driven LIF/LIFR axis improves the therapeutic efficacy of gemcitabine and nab-paclitaxel in pancreatic cancer by Rakesh Bhatia, Imran Khan, Xiaoqi Li, Shailendra Gautam, Parthasarathy Seshacharyulu, Zahraa Wajih Alsafwani, Namita Bhyravbhatla, Moorthy P. Ponnusamy, Maneesh Jain, Mokenge Malafa, Santhamma Bindu, Ahmed Gulzar, Hareesh Nair, Surinder K. Batra, Sushil Kumar

Get full text

Defining best practices for tissue procurement in immuno-oncology clinical trials: consensus statement from the Society for Immunotherapy of Cancer Surgery Committee by Lisa H Butterfield, Howard L Kaufman, Steven A Rosenberg, Simon Turcotte, Robert L Ferris, Craig L Slingluff, David Byrd, Jyothi Sethuraman, Brian Gastman, Michael Lim, Michael T Lotze, Mokenge Malafa, Adekunle Odunsi, Fumito Ito, Genevieve Boland, Pranav Murthy, Adam Berger, Haider Mahdi, Piyush K Agarwal, Stephen Broderick, Peter E Fecci, Yuman Fong, Stephanie L Goff, Matthew M Grabowski, Carol D Morris, Rogerio I Neves, Sara I Pai, Sangeetha Prabhakaran, Ragheed Saoud, Joseph Skitzki, Vernon K Sondak, John B Sunwoo, Cecilia CS Yeung

Get full text